| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Immunovant, Inc. | Chief Financial Officer | Common Stock | 208,388 | $3,059,135 | $14.68 | 01 May 2025 | Direct |
| Immunovant, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 293,505 | 01 May 2025 | Direct | ||
| Landos Biopharma, Inc. | Director | Stock Option (right to buy) | 0 | 23 May 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | 01 May 2025 | 2 | $0 | 4 | Chief Financial Officer | 05 May 2025, 19:30 |
| IMVT | Immunovant, Inc. | 21 Apr 2025 | 0 | $0 | 3 | Chief Financial Officer | 28 Apr 2025, 17:03 |
| /report/000141588924014341-girao-tiago-2024-05-23 | Landos Biopharma, Inc. | 23 May 2024 | 3 | $0 | 4 | Director | 23 May 2024, 17:45 |
| /report/000120919123031945-girao-tiago-2023-05-23 | Landos Biopharma, Inc. | 23 May 2023 | 1 | $0 | 4 | Director | 24 May 2023, 17:55 |
| /report/000120919122035284-girao-tiago-2022-06-07 | Landos Biopharma, Inc. | 07 Jun 2022 | 1 | $0 | 4 | Director | 09 Jun 2022, 08:53 |
| /report/000120919122030046-girao-tiago-2022-05-16 | Landos Biopharma, Inc. | 16 May 2022 | 1 | $0 | 4 | Director | 18 May 2022, 16:29 |